ProfileGDS5678 / 1442624_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 52% 47% 49% 47% 56% 48% 47% 47% 47% 47% 47% 45% 47% 47% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3102652
GSM967853U87-EV human glioblastoma xenograft - Control 23.1147547
GSM967854U87-EV human glioblastoma xenograft - Control 33.1630649
GSM967855U87-EV human glioblastoma xenograft - Control 43.039947
GSM967856U87-EV human glioblastoma xenograft - Control 53.3613456
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2354148
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.194147
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1032647
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0802747
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0957747
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1058247
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0218245
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1165447
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.1151147